Contribution of anti-ryanodine receptor antibody to impairment of excitation-contraction coupling in myasthenia gravis

Clinical Neurophysiology

Volumn 123, Issue 6, 2012, Pages 1242-1247

  Imai, Tomihiro ^a   Tsuda, Emiko ^a   Hozuki, Takayoshi ^a   Yoshikawa, Hiroaki ^b   Yamauchi, Rika ^a   Saitoh, Masaki ^a   Hisahara, Shin ^a   Motomura, Masakatsu ^c   Kawamata, Jun ^a   Shimohama, Shun ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

Bite force; Excitation contraction coupling; Masseter; Myasthenia gravis; Repetitive nerve stimulation; Ryanodine receptor

Indexed keywords

ANTIBODY; RYANODINE RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPOUND MUSCLE ACTION POTENTIAL; CONTROLLED STUDY; EXCITATION CONTRACTION COUPLING; FEMALE; HUMAN; LATENT PERIOD; MALE; MANDIBLE; MASSETER MUSCLE; MASTICATION; MOVEMENT RELATED POTENTIAL; MUSCLE ACTION POTENTIAL; MYASTHENIA GRAVIS; NERVE STIMULATION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; PRIORITY JOURNAL; TRIGEMINAL MOTOR NUCLEUS;

ACTION POTENTIALS; ADULT; AGED; AUTOANTIBODIES; BITE FORCE; EXCITATION CONTRACTION COUPLING; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 84861457512     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2011.10.038     Document Type: Article

References (36)

1. Bhat M.B., Zhao J., Takeshima H., Ma J. Functional calcium release channel formed by the carboxyl-terminal portion of ryanodine receptor. Biophys J 1997, 73:1329-1336.
2. Franzini-Armstrong C., Nunzi G. Junctional feet and particles in the triads of a fast-twitch muscle fibre. J Muscle Res Cell Motil 1983, 4:233-252.
3. Imai T, Tsuda E, Hozuki T, Hisahara S, Nonaka M, Shimohama S. Measurement of excitation-contraction coupling time of masseter in lower jaw movement. In: The XVIth international SFEMG and QEMG course and the IXth QEMG conference proceedings; 2007. p. 187.
4. Imai T., Tsuda E., Toyoshima T., Yoshikawa H., Motomura M., Shimohama S. Anti-ryanodine receptor-positive acetylcholine receptor-negative myasthenia gravis: evidence of impaired E-C coupling. Muscle Nerve 2011, 43:294-295.
5. Inui M., Saito A., Fleischer S. Purification of the ryanodine receptor and identity with feet structures of junctional terminal cisternae of sarcoplasmic reticulum from fast skeletal muscle. J Biol Chem 1987, 262:1740-1747.
6. Iwasa K. Striational autoantibodies in myasthenia gravis mainly react with ryanodine receptor. Muscle Nerve 1997, 20:753-756.
7. Jaretzki A., Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., et al. Myasthenia gravis: recommendations for clinical research standards. Neurology 2000, 55:16-23.
8. Kumura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice 2001, Oxford University Press, New York, p. 263. 3rd ed.
9. Kouyoumdjian J.A., Stålberg E. Reference jutter values for concentric needle electrodes in voluntarily activated extensor digitorum communis and orbicularis oculi muscles. Muscle Nerve 2008, 37:694-699.
10. Krarup C. Electrical and mechanical responses in the platysma and in the adductor pollicis muscle: in normal subjects. J Neurol Neurosurg Psychiatry 1977, 40:234-240.
11. Krarup C. Electrical and mechanical responses in the platysma and in the adductor pollicis muscle: in patients with myasthenia gravis. J Neurol Neurosurg Psychiatry 1977, 40:241-249.
12. Leong P., MacLennan D.H. A 37-amino acid sequence in the skeletal muscle ryanodine receptor interacts with the cytoplasmic loop between domains II and III in the skeletal muscle dihydropyridine receptor. J Biol Chem 1998, 273:7791-7794.
13. Leong P., MacLennan D.H. The cytoplasmic loops between domains II and III and domains III and IV in the skeletal muscle dihydropyridine receptor bind to a contiguous site in the skeletal muscle ryanodine receptor. J Biol Chem 1998, 273:29958-29964.
14. Maruta T., Yoshikawa H., Fukasawa S., Umeshita S., Inaoka Y., Edahiro S., et al. Autoantibody to dihydropyridine receptor in myasthenia gravis. J Neuroimmunol 2009, 208:125-129.
15. Mygland å, Tysnes O.B., Matre R., Volpe P., Aarli J.A., Gilhus N.E. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Ann Neurol 1992, 32:589-591.
16. Nagai I., Tanaka M., Noguchi Y., Suda T., Sonoda T., Kohama G. Changes on occlusal state of patients with mandibular prognathism after orthognathic surgery: a pilot study. Br J Oral Maxillofac Surg 2001, 39:429-433.
17. Nakata M., Kuwabara S., Kawaguchi N., Takahashi H., Misawa S., Kanai K., et al. Is excitation-contraction coupling impaired in myasthenia gravis?. Clin Neurophysiol 2007, 118:1144-1148.
18. Oosterhuis H., Bethlem J. Neurogenic muscle involvement in myasthenia gravis: a clinical and histopathological study. J Neurol Neurosurg Psychiatry 1973, 36:244-254.
19. Romi F., Aarli J.A., Gilhus N.E. Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features. Eur J Neurol 2007, 14:617-620.
20. Rousseff R.T., Khuraibet A.J., Al-Shubaili A.F., Tzvetanov P. Stimulated jitter in the masseter muscle: normative values. Muscle Nerve 2007, 35:243-245.
21. Rubin D.I., Harper C.M., Auger R.G. Trigeminal nerve repetitive stimulation in myasthenia gravis. Muscle Nerve 2004, 29:591-596.
22. Saito A., Seiler S., Chu A., Fleischer S. Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle. J Cell Biol 1984, 99:875-885.
23. Shiraishi H., Motomura M., Yoshimura T., Fukudome T., Fukuda T., Nakao Y., et al. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol 2005, 57:289-293.
24. 3H]-ryanodine to sarcoplasmic reticulum. Muscle Nerve 1998, 21:329-335.
25. Skeie G.O., Mygland å, Treves S., Gilhus N.E., Aarli J.A., Zortato F. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro. Muscle Nerve 2003, 27:81-89.
26. Slomic A., Rosenfalck A., Buchthal F. Electrical and mechanical responses of normal and myasthenic muscle: with particular reference to the staircase phenomenon. Brain Res 1968, 10:1-78.
27. Somnier F.E., Trojaborg W. Neurophysiological evaluation in myasthenia gravis: a comprehensive study of a complete patient population. Electroencephalogr Clin Neurophysiol 1993, 89:73-78.
28. Somnier F.E., Skeie G.O., Aarli J.A., Trojaborg W. EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis. Eur J Neurol 1999, 6:555-563.
29. Takamori M., Motomura M., Kawaguchi N., Nemoto Y., Hattori T., Yoshikawa H., et al. Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis. Neurology 2004, 62:1894-1896.
30. Tanabe T., Beam K.G., Adams B., Niidome T., Numa S. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature 1990, 346:567-569.
31. Timerman A.P., Ogunbumni E., Freund E., Wiederrecht G., Marks A.R., Fleischer S. The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein: dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. J Biol Chem 1993, 268:22992-22999.
32. Tsuda E., Imai T., Hozuki T., Yamauchi R., Saitoh M., Hisahara S., et al. Correlation of bite force with excitation-contraction coupling time of the masseter in myasthenia gravis. Clin Neurophysiol 2010, 121:1051-1058.
33. van der Bilt A., Weijnen F.G., Bosman F., van der Glas H.W., Kuks J.B.M. Controlled study of EMG activity of the jaw closers and openers during mastication in patients with myasthenia gravis. Eur J Oral Sci 2001, 109:160-164.
34. Weijnen F.G., van der Bilt A., Wokke J.J., Kuks J.B.M., van der Glas H.W., Bosman F. Maximal bite force and surface EMG in patients with myasthenia gravis. Muscle Nerve 2000, 23:1694-1699.
35. Wolfe G.I., Herbelin L., Nations S.P., Foster B., Bryan W.W., Barohn R.J. Myasthenia gravis activities of daily living profile. Neurology 1999, 52:1487-1489.
36. 2+release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J Biol Chem 1990, 265:2244-2256.